1. The Future of the Quinolones

   • Vincent T. Andriole

   State-of-The-Art Presentations 18 November 2012 Pages: 1 - 7

2. Quinolone Mode of Action — New Aspects

   • David C. Hooper

   State-of-The-Art Presentations 18 November 2012 Pages: 8 - 14

3. Mechanisms of Resistance to Quinolones

   • E. Cambau
   • L. Gutmann

   State-of-The-Art Presentations 18 November 2012 Pages: 15 - 23

4. The Epidemiology of Bacterial Resistance to Quinolones

   • J. F. Acar
   • T. F. O’Brien
   • R. N. Jones

   State-of-The-Art Presentations 18 November 2012 Pages: 24 - 28

5. Quinolones in Intracellular Infections

   • Jean-Claude Pechère

   State-of-The-Art Presentations 18 November 2012 Pages: 29 - 36

6. Use of the Quinolones in Paediatrics

   • Urs B. Schaad

   State-of-The-Art Presentations 18 November 2012 Pages: 37 - 41

7. The Use of Quinolones in Developing Countries

   • E. Rodríguez-Noriega
   • R. Morfín-Otero
   • S. Esparza-Ahumada

   State-of-The-Art Presentations 18 November 2012 Pages: 42 - 45

8. Postmarketing Surveillance of Quinolones, 1990 to 1992

   • Peter Davey
   • Tom McDonald

   State-of-The-Art Presentations 18 November 2012 Pages: 46 - 53

9. Synergy and Antagonism of Fluoroquinolones with Other Classes of Antimicrobial Agents

   • Harold C. Neu

   State-of-The-Art Presentations 18 November 2012 Pages: 54 - 58

10. Safety and Tolerability of Fluoroquinolones

    • S. Ragnar Norrby
    • Paul S. Lietman

    State-of-The-Art Presentations 18 November 2012 Pages: 59 - 64

11. Fluoroquinolones: Interaction Profile during Enteral Absorption

    • Karl-Matthias Deppermann
    • Hartmut Lode

    State-of-The-Art Presentations 18 November 2012 Pages: 65 - 72

12. Use of the Quinolones for the Prophylaxis and Therapy of Infections in Immunocompromised Hosts

    • Georg Maschmeyer

    State-of-The-Art Presentations 18 November 2012 Pages: 73 - 80

13. Use of the Quinolones in the Prophylaxis and Treatment of Granulocytopenic Immunocompromised Cancer Patients

    • P. Van der Auwera
    • J. Gérain

    State-of-The-Art Presentations 18 November 2012 Pages: 81 - 90

14. Quinolones in the Treatment of Lower Respiratory Tract Infections in Adult Patients

    • Claude Carbon

    State-of-The-Art Presentations 18 November 2012 Pages: 91 - 97

15. Fluoroquinolones in the Treatment of Cystic Fibrosis

    • N. Høiby
    • S. S. Pedersen
    • C. Koch

    State-of-The-Art Presentations 18 November 2012 Pages: 98 - 101

16. Fluoroquinolones and Surgical Prophylaxis

    • P. Dellamonica
    • E. Bernard

    State-of-The-Art Presentations 18 November 2012 Pages: 102 - 113

17. Quinolones in the Treatment of Acute Bacterial Diarrhoeal Diseases

    • H. Erdal Akalin

    State-of-The-Art Presentations 18 November 2012 Pages: 114 - 118

18. Quinolones in Salmonella typhi Infection

    • Herbert L. DuPont

    State-of-The-Art Presentations 18 November 2012 Pages: 119 - 124

19. Impact of the Fluoroquinolones on Gastrointestinal Flora

    • Volkan Korten
    • Barbara E. Murray

    State-of-The-Art Presentations 18 November 2012 Pages: 125 - 133

20. Quinolones in Sexually Transmitted Diseases

    • Geoffrey L. Ridgway

    State-of-The-Art Presentations 18 November 2012 Pages: 134 - 138

21. Management of Lower Urinary Tract Infections

    • Ross R. Bailey

    State-of-The-Art Presentations 18 November 2012 Pages: 139 - 144

22. Hydrophobicity of 11 Fluoroquinolones and Antibacterial Activity, Activity against DNA Gyrase and Uptake

    • S. Bazile
    • N. J. Moreau
    • M. Essiz

    Poster Presentations 18 November 2012 Pages: 145 - 147

23. Affinity of Sparfloxacin and 4 Other Fluoroquinolones for Magnesium and Effect on Antibacterial Activity

    • S. Lecomte
    • C. Coupry
    • N. J. Moreau

    Poster Presentations 18 November 2012 Pages: 148 - 149

24. Effect of Cations and EDTA upon the Activity of 18 Quinolones, Gentamicin, Ceftazidime and Polymixin against Gram-Negative and Gram-Positive Bacteria

    • A. J. H. Marshall
    • L. J. V. Piddock

    Poster Presentations 18 November 2012 Pages: 150 - 151

25. Sensitivity of Community- and Hospital-Acquired Bacterial Isolates to Sparfloxacin in Comparison with Other Antibiotics

    • Josef Focht
    • Kristof Nösner
    • Michael Kresken

    Poster Presentations 18 November 2012 Pages: 152 - 156

26. Antimicrobial Activities of Ciprofloxacin and 6 Other New Quinolones In Vitro against Recent Clinical Pathogens

    • Satoshi Nakashio
    • Seiji Hori
    • Jingoro Shimada

    Poster Presentations 18 November 2012 Pages: 157 - 158

27. Comparative In Vitro Activity of Ofloxacin and Other Antimicrobial Agents Used in Oral Therapy in General Practice

    • J. Focht
    • H. Kraus
    • K. Nösner

    Poster Presentations 18 November 2012 Pages: 159 - 160

28. 6 Years of Experience with Sensitivity Testing of Various Gram-Negative and Gram-Positive Clinical Strains to Ofloxacin

    • M. L. Zaremba
    • M. Rozkiewicz
    • J. Borowski

    Poster Presentations 18 November 2012 Pages: 161 - 162

29. MIC Audit of Routine Ciprofloxacin Sensitivity Testing

    • A. King
    • I. Phillips
    • G. Tillotson

    Poster Presentations 18 November 2012 Pages: 163 - 164

30. Annual Changes in the Susceptibility of Clinical Isolates to Ofloxacin

    • Takayuki Takubo

    Poster Presentations 18 November 2012 Pages: 165 - 166

31. The North American Component (USA, Canada) of an International Comparative MIC Trial Monitoring Ofloxacin Resistance

    • Daryl Hoban
    • Ronald N. Jones

    Poster Presentations 18 November 2012 Pages: 167 - 169

32. Surveillance of Bacterial Resistance to Quinolones

    • Fu Wang
    • De-Mei Zhu
    • Yu-qing Wang

    Poster Presentations 18 November 2012 Pages: 170 - 171

33. Clinical and Experimental Study of the Appearance of Norfloxacin-Resistant P. aeruginosa in UTI

    • S. Onodera
    • H. Kiyota
    • S. Iyobe

    Poster Presentations 18 November 2012 Pages: 172 - 173

34. Prevalence of Ciprofloxacin Resistance in Multiresistant Gram-Negative Intensive Care Unit Isolates

    • C. M. Khurana
    • B. R. Wojack

    Poster Presentations 18 November 2012 Pages: 174 - 175

35. High Level Quinolone Resistance among Escherichia coli Clinical Isolates

    • T. Alarcón
    • J. Pita
    • M. López-Brea

    Poster Presentations 18 November 2012 Pages: 176 - 176

36. Emergence of Resistance of Uropathogens to Quinolones

    • Kurt G. Naber
    • Wolfgang Witte
    • Bernd Wiedemann

    Poster Presentations 18 November 2012 Pages: 177 - 178

37. Resistance to Quinolones and Other Antibiotics Assessed by Factor Analysis

    • L. Leibovici
    • A. J. Wysenbeek
    • M. Drucker

    Poster Presentations 18 November 2012 Pages: 179 - 179

38. In Vitro and In Vivo Antibacterial Activity of E-4868

    • M. A. Xicota
    • R. Coll
    • J. Guinea

    Poster Presentations 18 November 2012 Pages: 180 - 180

39. In Vitro Activities of AM-1155 against Chlamydia spp. and M. avium Complex

    • R. Soejima
    • N. Miyashita
    • Y. Niki

    Poster Presentations 18 November 2012 Pages: 181 - 181

40. In Vitro Antibacterial Activity of AM-1155

    • K. Hirai
    • T. Yasue
    • K. Nishino

    Poster Presentations 18 November 2012 Pages: 182 - 183

41. Comparative In Vitro Activity of AM-1155, a New Quinolone, against Anaerobic Bacteria

    • K. Ueno
    • K. Watanabe
    • Y. Tanaka

    Poster Presentations 18 November 2012 Pages: 184 - 186

42. In Vitro Activity of PD 131628 against Anaerobic Bacteria

    • C. E. Nord
    • A. Hagelbäck

    Poster Presentations 18 November 2012 Pages: 187 - 187

43. Comparative In Vitro Activity of PD 131628, the Microbiologically Active Constituent of the Prodrug CI-990 (PD 131112)

    • David Felmingham
    • M. J. Robbins
    • R. N. Gruneberg

    Poster Presentations 18 November 2012 Pages: 188 - 189

44. In Vitro Activity of PD 131628 and Effects on Virulence and OMPs

    • P. Cipriani
    • A. Giordano
    • F. Filadoro

    Poster Presentations 18 November 2012 Pages: 190 - 191

45. Comparative In Vitro Antibacterial Activity of PD 131628, the Active Metabolite of CI-990

    • J. J. Callanan
    • D. O. J. Roditi
    • A. A. Forder

    Poster Presentations 18 November 2012 Pages: 192 - 193

46. Susceptibility of 170 Penicillin-Susceptible and -Resistant Pneumococci to Various Antimicrobials

    • S. K. Spangler
    • M. R. Jacobs
    • Peter C. Appelbaum

    Poster Presentations 18 November 2012 Pages: 194 - 195

47. Activity of Quinolone Antibacterials against Streptococcus pneumoniae

    • I. Morrissey
    • J. T. Smith

    Poster Presentations 18 November 2012 Pages: 196 - 197

48. Induction of Resistance of Streptococcus pneumoniae to Levofloxacin, Ciprofloxacin and Norfloxacin In Vitro

    • K. P. Fu
    • S. C. Lafredo
    • B. D. Foleno

    Poster Presentations 18 November 2012 Pages: 198 - 198

49. Comparative In Vitro Activity of Sparfloxacin against Gram-Positive Cocci

    • Sesin Kocagöz
    • Deniz Gür
    • H. Erdal Akalin

    Poster Presentations 18 November 2012 Pages: 199 - 200

50. Increased Incidence of Gram-Positive Pathogens Subsequent to Quinolone Therapy in UTI

    • Margareta Taufer
    • H. Mailer
    • G. Wandschneider

    Poster Presentations 18 November 2012 Pages: 201 - 201